Financial Year |
March 31 2023 |
Monetary Funds |
838,497,766.55 |
Held-for-trading Financial Assets |
18,000,000.00 |
Notes Receivable |
9,545,468.56 |
Accounts Receivable |
909,467,114.94 |
Advances to Suppliers |
200,119,133.13 |
Other Receivables |
39,006,726.80 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
1,505,800,166.19 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
2,574,730.42 |
Total Current Assets |
4,048,099,341.79 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
150,580,363.24 |
Investment Properties |
-- |
Fixed Assetes |
1,185,096,911.22 |
Under-construction Projects |
3,534,527.45 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
146,557,933.17 |
R&D expenses |
-- |
Goodwill |
62,497,545.59 |
Long-Term Deferred and Prepaid Expenses |
7,305,613.18 |
Deferred Income Tax Assets |
147,482,137.06 |
Other Non-Current Assets |
67,284,756.77 |
Sub-Total of Non-Current Assets |
1,930,294,037.95 |
Total Assets |
5,978,393,379.74 |
Short-Term Loans |
-- |
Trading Financial liabilities |
-- |
Notes Payable |
287,050,710.12 |
Accounts Payable |
424,380,657.01 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
26,887,383.52 |
Taxes Payable |
24,994,675.24 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
34,734,938.90 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
1,884,160.73 |
Other Current Liabilities |
121,347,438.37 |
Sub-Total of Current Liabilities |
2,365,077,742.19 |
Long-term Loans |
-- |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
39,185,713.15 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
170,863,180.20 |
Total Liabilities |
2,535,940,922.39 |
Paid-In Capital(Or Share Stock) |
842,271,055.00 |
Capital Surplus |
2,341,438,460.24 |
Surplus Reserve |
99,408,928.65 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
210,478,503.22 |
Minority Stockholder's Interest |
55,121,564.15 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,387,330,893.20 |
Owner's Equity(Stockholder's Equity) |
3,442,452,457.35 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
5,978,393,379.74 |